10X Genomics Inc
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and … Read more
Market Cap & Net Worth: 10X Genomics Inc (TXG)
10X Genomics Inc (NASDAQ:TXG) has a market capitalization of $2.11 Billion ($2.11 Billion) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #4877 globally and #2976 in its home market, demonstrating a -13.49% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 10X Genomics Inc's stock price $18.09 by its total outstanding shares 116474179 (116.47 Million).
10X Genomics Inc Market Cap History: 2019 to 2026
10X Genomics Inc's market capitalization history from 2019 to 2026. Data shows change from $8.88 Billion to $2.11 Billion (-15.15% CAGR).
Index Memberships
10X Genomics Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.09% | #126 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.01% | #585 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.54 Trillion | 0.13% | #78 of 263 |
Weight: 10X Genomics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
10X Genomics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 10X Genomics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.74x
10X Genomics Inc's market cap is 2.74 times its annual revenue
1.54x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $8.88 Billion | $245.89 Million | -$31.25 Million | 36.12x | N/A |
| 2020 | $16.49 Billion | $298.85 Million | -$542.73 Million | 55.19x | N/A |
| 2021 | $17.35 Billion | $490.49 Million | -$58.22 Million | 35.37x | N/A |
| 2022 | $4.24 Billion | $516.41 Million | -$166.00 Million | 8.22x | N/A |
| 2023 | $6.52 Billion | $618.73 Million | -$255.10 Million | 10.53x | N/A |
| 2024 | $1.67 Billion | $610.78 Million | -$182.63 Million | 2.74x | N/A |
Competitor Companies of TXG by Market Capitalization
Companies near 10X Genomics Inc in the global market cap rankings as of March 18, 2026.
Key companies related to 10X Genomics Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
10X Genomics Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, 10X Genomics Inc's market cap moved from $8.88 Billion to $ 2.11 Billion, with a yearly change of -15.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.11 Billion | +10.91% |
| 2025 | $1.90 Billion | +13.58% |
| 2024 | $1.67 Billion | -74.34% |
| 2023 | $6.52 Billion | +53.57% |
| 2022 | $4.24 Billion | -75.54% |
| 2021 | $17.35 Billion | +5.20% |
| 2020 | $16.49 Billion | +85.70% |
| 2019 | $8.88 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of 10X Genomics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.11 Billion USD |
| MoneyControl | $2.11 Billion USD |
| MarketWatch | $2.11 Billion USD |
| marketcap.company | $2.11 Billion USD |
| Reuters | $2.11 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.